Phase III trial of esflurbiprofen (TT-063) analgesic patch in Japanese patients with osteoarthritis of the knee
Phase of Trial: Phase III
Latest Information Update: 31 May 2016
At a glance
- Drugs Esflurbiprofen (Primary) ; Flurbiprofen
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 22 Jul 2015 According to Taisho Pharmaceuticals media release, company has announced two results at the Annual Meeting of the Japanese Clinical Orthopaedic Association.
- 21 Jul 2015 Results published in Taisho Pharmaceutical media release.
- 01 Apr 2015 New trial record